Form 4: Avidity Biosciences Executive Exercises Options and Sells Shares Under 10b5-1 Plan

Teresa McCarthy, Chief Human Resources Officer of Avidity Biosciences, exercised stock options and sold 25,000 shares of common stock at an average price of $40.4017, pursuant to a pre-arranged Rule 10b5-1 trading plan.

Summary

• On September 11, 2024, Teresa McCarthy, the Chief Human Resources Officer of Avidity Biosciences, exercised stock options to acquire 25,000 shares of common stock at a price of $14.22 per share.
• Simultaneously, McCarthy sold 25,000 shares of Avidity Biosciences common stock at a weighted-average price of $40.4017 per share, with individual sales prices ranging from $39.80 to $41.00.
• These transactions were executed under a pre-existing Rule 10b5-1 trading plan adopted on June 12, 2024.
• Following these transactions, McCarthy directly owns 57,171 shares of Avidity Biosciences common stock and 132,500 stock options.

Sentiment

Score: 5

Explanation: Neutral sentiment. The transactions are part of a pre-planned trading plan and don't necessarily indicate a change in the executive's outlook on the company.

Industry Context

Executive stock transactions are common and are often pre-planned using Rule 10b5-1 plans to avoid insider trading accusations. The market typically analyzes these transactions to gauge executive sentiment, but pre-planned sales often have limited informational value.

Comparison to Industry Standards

• Executive compensation packages often include stock options as a form of long-term incentive.
• Rule 10b5-1 trading plans are a standard practice among corporate executives to manage their stock sales in a compliant manner.
• Comparing McCarthy's transactions to those of executives at similar biotech companies like Alnylam Pharmaceuticals or Ionis Pharmaceuticals would provide a benchmark for assessing the scale and frequency of such activities.

Stakeholder Impact

• The transactions may have a minor impact on shareholders due to the change in ownership, but the pre-planned nature of the sales mitigates concerns about insider information.

Key Dates